related documents TOCILIZUMAB FOR REFRACTORY OR RELAPSING GIANT CELL ARTERITIS: AUDIT DATA FROM THE BRISTOL AND BATH REGIONAL MULTIDISCIPLINARY MEETINGS 2018-2021 Conference Proceeding
